Abstract
Lung lavage levels of angiotensin-converting enzyme (ACE)-like activity were increased in C57BL/6 mice with Bacille Calmette-Guérin (BCG)-induced chronic granulomatous pulmonary inflammation and splenomegaly. Contrariwise, ACE activity was not increased in lung lavage fluids of CBA mice that developed only minimal pulmonary inflammation in response to BCG. ACE-like activity correlated with the intensity of inflammation and Captopril, a specific competitive inhibitor of ACE activity, markedly suppressed the induction and maintenance of the BCG-induced inflammatory response in both lungs and spleen. It was necessary, however, to provide sustained treatment with large doses of Captopril in order to reduce the inflammatory response. After a single intraperitoneal injection of Captopril, ACE levels in lung lavage of BCG-injected mice were reduced but returned to preinjection levels or greater within 24 h. The highest dose of Captopril was more effective in reducing the lung fluid level of ACE in BCG-inflamed lungs. This suggests that sustained daily injections of Captopril were necessary to maintain reduced ACE levels. In vitro studies indicated that high concentrations of Captopril did not affect macrophage mobility or chemotactic activity for macrophages. Thus, ACE may act as a molecular mediator of BCG-induced granulomatous inflammation in the lung.
Full text
PDF






Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allen E. M., Moore V. L., Stevens J. O. Strain variation in BCG-induced chronic pulmonary inflammation in mice. I. Basic model and possible genetic control by non-H-2 genes. J Immunol. 1977 Jul;119(1):343–347. [PubMed] [Google Scholar]
- Allen E. M., Moore V. L. Suppression of phytohemagglutinin and lipopolysaccharide responses in mouse spleen cells by Bacillus Calmette-Guerin. J Reticuloendothel Soc. 1979 Oct;26(4):349–356. [PubMed] [Google Scholar]
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- Friedland J., Silverstein E. A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am J Clin Pathol. 1976 Aug;66(2):416–424. doi: 10.1093/ajcp/66.2.416. [DOI] [PubMed] [Google Scholar]
- Lieberman J., Nosal A., Schlessner A., Sastre-Foken A. Serum angiotensin-converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis. Am Rev Respir Dis. 1979 Aug;120(2):329–335. doi: 10.1164/arrd.1979.120.2.329. [DOI] [PubMed] [Google Scholar]
- Moore V. L., Mondloch V. M., Pedersen G. M., Schrier D. J., Allen E. M. Strain variation in BCG-induced chronic pulmonary inflammation in mice: control by a cyclophosphamide-sensitive thymus-derived suppressor cell. J Immunol. 1981 Jul;127(1):339–342. [PubMed] [Google Scholar]
- Schrier D. J., Allen E. M., Moore V. L. BCG-induced macrophage suppression in mice: suppression of specific and nonspecific antibody-medicated and cellular immunologic responses. Cell Immunol. 1980 Dec;56(2):347–356. doi: 10.1016/0008-8749(80)90110-0. [DOI] [PubMed] [Google Scholar]
- Silverstein E., Friedland J. Elevated serum and spleen angiotensin converting enzyme and serum lysozyme in Gaucher's disease. Clin Chim Acta. 1977 Jan 3;74(1):21–25. doi: 10.1016/0009-8981(77)90382-5. [DOI] [PubMed] [Google Scholar]
- Silverstein E., Friedland J., Kitt M., Lyons H. A. Increased serum angiotensin converting enzyme activity in sarcoidosis. Isr J Med Sci. 1977 Oct;13(10):995–1000. [PubMed] [Google Scholar]
- Silverstein E., Friedland J., Lyons H. A., Gourin A. Markedly elevated angiotensin converting enzyme in lymph nodes containing non-necrotizing granulomas in sarcoidosis. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2137–2141. doi: 10.1073/pnas.73.6.2137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silverstein E., Friedland J., Lyons H. A. Serum angiotensin converting enzyme in sarcoidosis: clinical significance. Isr J Med Sci. 1977 Oct;13(10):1001–1006. [PubMed] [Google Scholar]
- Silverstein E., Friedland J., Vuletin J. C. Marked elevation of serum angiotension-converting enzyme and hepatic fibrosis containing long-spacing collagen fibrils in type 2 acute neuronopathic Gaucher's disease. Am J Clin Pathol. 1978 Apr;69(4):467–471. doi: 10.1093/ajcp/69.4.467. [DOI] [PubMed] [Google Scholar]
- Silverstein E., Pertschuk L. P., Friedland J. Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6646–6648. doi: 10.1073/pnas.76.12.6646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Soffer R. L. Angiotensin-converting enzyme and the regulation of vasoactive peptides. Annu Rev Biochem. 1976;45:73–94. doi: 10.1146/annurev.bi.45.070176.000445. [DOI] [PubMed] [Google Scholar]
- Swartz S. L., Williams G. H., Hollenberg N. K., Levine L., Dluhy R. G., Moore T. J. Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest. 1980 Jun;65(6):1257–1264. doi: 10.1172/JCI109788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weinstock J. V., Ehrinpreis M. N., Boros D. L., Gee J. B. Effect of SQ 14225, an inhibitor of angiotensin I-converting enzyme, on the granulomatous response to Schistosoma mansoni eggs in mice. J Clin Invest. 1981 Apr;67(4):931–936. doi: 10.1172/JCI110142. [DOI] [PMC free article] [PubMed] [Google Scholar]